TokensHive
Dashboard 🇪🇸
Advertisement

Polymarket Market

Prediction market

Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.

Upcoming
MarketLive pricing
Probability
50%
Liquidity
$51.09K
Best bid
1%
Best ask
99%
Spread
98%
Last trade
50%

Outcomes

Market outcomes

Yes 50% Current quote
No 50% Current quote

Live pricing

Pricing and liquidity

Current bid, ask, midpoint, spread, and market depth for this outcome.

Best bid
1%
Best ask
99%
Midpoint
50%
Spread
98%
Last trade
50%
Depth
25,001.68 / 26,090.48

Price history

Waiting for price history

History unavailable

Bids

PriceSize
1%18,905.39
2%7.36
3%26.27
5%10
6%1,800
7%300
8%6.06
11%600

Asks

PriceSize
99%18,905.06
98%7.28
95%300
94%1,800
93%6.99
92%26.27
89%600
80%1,350

Trades

Recent trades

Latest visible trades for this market.

  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 50% 20 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    Yes 49% 12 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 50% 0.48 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 50% 43 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 50% 30.36 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 50% 52.31 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 50% 19 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 18.9% 52.31 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 5% 43 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 11% 20 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 11% 32 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
    No 11% 30.36 shares
Advertisement
Advertisement